Your browser doesn't support javascript.
loading
A national study confirms that Escherichia coli from Australian commercial layer hens remain susceptible to critically important antimicrobials.
Abraham, Rebecca; Allison, Hui San; Lee, Terence; Pavic, Anthony; Chia, Raymond; Hewson, Kylie; Lee, Zheng Zhou; Hampson, David J; Jordan, David; Abraham, Sam.
Afiliación
  • Abraham R; Antimicrobial Resistance and Infectious Diseases Laboratory, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, Australia.
  • Allison HS; Antimicrobial Resistance and Infectious Diseases Laboratory, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, Australia.
  • Lee T; Antimicrobial Resistance and Infectious Diseases Laboratory, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, Australia.
  • Pavic A; Birling Avian Laboratories, Bringelly, New South Wales, Australia.
  • Chia R; Australian Eggs, North Sydney, New South Wales, Australia.
  • Hewson K; Sativus Pty Ltd, Beenleigh, Queensland, Australia.
  • Lee ZZ; Antimicrobial Resistance and Infectious Diseases Laboratory, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, Australia.
  • Hampson DJ; Antimicrobial Resistance and Infectious Diseases Laboratory, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, Australia.
  • Jordan D; New South Wales Department of Primary industries, Wollongbar, New South Wales, Australia.
  • Abraham S; Antimicrobial Resistance and Infectious Diseases Laboratory, Harry Butler Institute, Murdoch University, Murdoch, Western Australia, Australia.
PLoS One ; 18(7): e0281848, 2023.
Article en En | MEDLINE | ID: mdl-37418382
ABSTRACT
Controlling the use of the most critically important antimicrobials (CIAs) in food animals has been identified as one of the key measures required to curb the transmission of antimicrobial resistant bacteria from animals to humans. Expanding the evidence demonstrating the effectiveness of restricting CIA usage for preventing the emergence of resistance to key drugs amongst commensal organisms in animal production would do much to strengthen international efforts to control antimicrobial resistance (AMR). As Australia has strict controls on antimicrobial use in layer hens, and internationally comparatively low levels of poultry disease due to strict national biosecurity measures, we investigated whether these circumstances have resulted in curtailing development of critical forms of AMR. The work comprised a cross-sectional national survey of 62 commercial layer farms with each assessed for AMR in Escherichia coli isolates recovered from faeces. Minimum inhibitory concentration analysis using a panel of 13 antimicrobials was performed on 296 isolates, with those exhibiting phenotypic resistance to fluoroquinolones (a CIA) or multi-class drug resistance (MCR) subjected to whole genome sequencing. Overall, 53.0% of isolates were susceptible to all antimicrobials tested, and all isolates were susceptible to cefoxitin, ceftiofur, ceftriaxone, chloramphenicol and colistin. Resistance was observed for amoxicillin-clavulanate (9.1%), ampicillin (16.2%), ciprofloxacin (2.7%), florfenicol (2.4%), gentamicin (1.0%), streptomycin (4.7%), tetracycline (37.8%) and trimethoprim/sulfamethoxazole (9.5%). MCR was observed in 21 isolates (7.0%), with two isolates exhibiting resistance to four antimicrobial classes. Whole genome sequencing revealed that ciprofloxacin-resistant (fluoroquinolone) isolates were devoid of both known chromosomal mutations in the quinolone resistance determinant regions and plasmid-mediated quinolone resistance genes (qnr)-other than in one isolate (ST155) which carried the qnrS gene. Two MCR E. coli isolates with ciprofloxacin-resistance were found to be carrying known resistance genes including aadA1, dfrA1, strA, strB, sul1, sul2, tet(A), blaTEM-1B, qnrS1 and tet(A). Overall, this study found that E. coli from layer hens in Australia have low rates of AMR, likely due to strict control on antimicrobial usage achieved by the sum of regulation and voluntary measures.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quinolonas / Escherichia coli Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Animals / Female / Humans País/Región como asunto: Oceania Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quinolonas / Escherichia coli Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Animals / Female / Humans País/Región como asunto: Oceania Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Australia